A microRNA signature of response to erlotinib is descriptive of TGFβ behaviour in NSCLC
Crossref DOI link: https://doi.org/10.1038/s41598-017-04097-7
Published Online: 2017-06-23
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Krentz Gober, Madeline
Collard, James P.
Thompson, Katherine
Black, Esther P.
Text and Data Mining valid from 2017-06-23
Version of Record valid from 2017-06-23
Article History
Received: 9 November 2016
Accepted: 8 May 2017
First Online: 23 June 2017
Competing Interests
: The authors declare that they have no competing interests.